Children’s Hospital Los Angeles Awarded $8.3 Million to Study Long-Term Effects of COVID in Children
Retrieved on:
Wednesday, January 26, 2022
Health, Consumer, Infectious Diseases, Hospitals, Children, Baby, Maternity, COVID-19, Heart rate, Name, Children's Hospital Los Angeles, Lung, Keck School of Medicine of USC, Blog, Disorder, USC, National, Parent, U.S. News & World Report, Headache, Patient, Hospital, Principal, Magnetic resonance imaging, Population, COVID, Hope, Medicine, Kidney, Child, Brain, Twitter, Multimedia, News, Research, Risk, Adult, Friends, Program, Instagram, Pregnancy, Heart, Electrocardiography, LinkedIn, Infection, NIH, CHLA, PASC, Severe acute respiratory syndrome coronavirus 2, Doctor of Philosophy, Physician, Liver, Caregiver, Sleep, Fatigue, MIS-C, YouTube, Electroencephalography, Pharmaceutical industry, Facebook, MD
Childrens Hospital Los Angeles is one of the few hospitals in California with a program dedicated to long COVID recovery care in children and young adults.
Key Points:
- Childrens Hospital Los Angeles is one of the few hospitals in California with a program dedicated to long COVID recovery care in children and young adults.
- The study also will focus on two other post-COVID/PASC conditions Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID vaccine-associated myocarditis .
- Founded in 1901, Children's Hospital Los Angeles is the highest-ranked hospital in California and fifth in the nation on the prestigious U.S. News & World Report Honor Roll of Best Childrens Hospitals.
- The hospital also operates the largest pediatric residency training program at a freestanding childrens hospital in the Western United States.